<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/">
  <channel>
    <title>20 Microns Ltd. (20MICRONS) — Tipsheet</title>
    <link>https://tipsheet.markets/company/20microns/</link>
    <atom:link href="https://tipsheet.markets/company/20microns/feed.xml" rel="self" type="application/rss+xml" />
    <description>Every Tipsheet Editorial note covering 20 Microns Ltd. (20MICRONS), newest first. Grounded in BSE/NSE primary-source filings.</description>
    <language>en-in</language>
    <lastBuildDate>Mon, 06 Jul 2026 10:22:46 GMT</lastBuildDate>
    <item>
      <title>20 Microns outlines ₹100 cr capex but yanks near-term profit guidance</title>
      <link>https://tipsheet.markets/20microns-20-microns-outlines-100-cr-capex-but-yanks-near-term-profit-guidance-99042/</link>
      <guid isPermaLink="true">https://tipsheet.markets/20microns-20-microns-outlines-100-cr-capex-but-yanks-near-term-profit-guidance-99042/</guid>
      <pubDate>Tue, 26 May 2026 17:12:28 GMT</pubDate>
      <description>A five-year plan to spend ₹100 crore targets 18% revenue growth by FY30. But management withdrew near-term profit guidance on the same call.</description>
      <content:encoded><![CDATA[<p><em>A five-year plan to spend ₹100 crore targets 18% revenue growth by FY30. But management withdrew near-term profit guidance on the same call.</em></p>
<h3>What’s new</h3><ul><li>Management detailed a ₹100 crore capex plan for Malaysia, mining infrastructure, and specialty R&amp;D.</li><li>Near-term profit guidance was withdrawn, citing geopolitical uncertainty.</li><li>Malaysia plant commissioning pushed to early FY27, contradicting earlier statements.</li></ul>
<h3>Why it matters</h3><p>The capex plan lays out where money will go. The guidance pullback undercuts the confidence needed to believe the plan will deliver. Contradicting its own prior commentary on timelines makes the contradiction the story, not the spending.</p>
<h3>What we’re watching</h3><ul><li>Whether the Malaysia plant starts in early FY27 or slips again.</li><li>If the 18% revenue-growth target survives without near-term profit guidance.</li><li>How paint-segment flatness is offset by polymer and rubber recovery.</li></ul>
<h3>The full read</h3><p>20 Microns' Q4 FY26 revenue rose <strong>14.8%</strong> year-on-year to <strong>₹222.1 crore</strong>. Full-year revenue was <strong>₹953.83 crore</strong>. The numbers are solid. The commentary is not. Management laid out a <strong>₹100 crore</strong> five-year capex plan targeting <strong>18%</strong> revenue growth by FY30. The money goes 40% to Malaysia, 20% to mining infrastructure, and 20% to specialty R&amp;D. But management simultaneously withdrew near-term profit guidance, citing geopolitical uncertainty, and pushed back the Malaysia plant commissioning to early FY27. That contradicts what it said on prior calls. Paint held flat at <strong>46%</strong> of revenue while polymer and rubber segments recovered. The capex plan is the headline. The guidance withdrawal is the real news. A management team confident in a five-year plan does not pull near-term guidance in the same breath.</p>
<p>Primary source: <a href="https://www.bseindia.com/corporates/ann.html?scrip=533022&dur=A">BSE</a> · <a href="https://www.nseindia.com/companies-listing/corporate-filings-announcements?symbol=20MICRONS">NSE</a></p>]]></content:encoded>
      <category>Earnings</category>
      <dc:creator>Tipsheet Editorial</dc:creator>
    </item>
    <item>
      <title>20 Microns&#39; cash flow triples to ₹86 cr as profit growth stays flat</title>
      <link>https://tipsheet.markets/20microns-20-microns-cash-flow-triples-to-86-cr-as-profit-growth-stays-flat-95621/</link>
      <guid isPermaLink="true">https://tipsheet.markets/20microns-20-microns-cash-flow-triples-to-86-cr-as-profit-growth-stays-flat-95621/</guid>
      <pubDate>Fri, 22 May 2026 16:38:53 GMT</pubDate>
      <description>Full-year profit grew just 6.9%, but operating cash flow surged on better working capital. The dividend is unchanged.</description>
      <content:encoded><![CDATA[<p><em>Full-year profit grew just 6.9%, but operating cash flow surged on better working capital. The dividend is unchanged.</em></p>
<h3>What’s new</h3><ul><li>FY26 standalone net profit rose 6.9% to ₹60.23 cr; consolidated profit was ₹66.67 cr.</li><li>Operating cash flow jumped to ₹85.90 cr from ₹26.45 cr, driven by better working capital.</li><li>The board recommended a final dividend of ₹1.25 per share, unchanged from last year.</li></ul>
<h3>Why it matters</h3><p>The growth is modest, but the cash-flow swing is real. A more-than-threefold jump in operating cash flow shows the company converted sales into actual cash far more efficiently. For a firm with steady but unspectacular revenue growth, that's the only surprise in these numbers.</p>
<h3>What we’re watching</h3><ul><li>Whether the cash-flow improvement holds in FY27 or was a one-time working-capital swing.</li><li>If the dividend is maintained or raised given the stronger cash position.</li><li>How input cost volatility affects margins in the coming quarters.</li></ul>
<h3>The full read</h3><p>20 Microns delivered steady, predictable growth for FY26. Standalone revenue rose <strong>3.7%</strong> to <strong>₹824.04 crore</strong>, and net profit climbed <strong>6.9%</strong> to <strong>₹60.23 crore</strong>. The fourth quarter was brighter, with revenue up <strong>12%</strong> to <strong>₹222.10 crore</strong> and profit surging <strong>16.9%</strong>. Consolidated numbers followed the same script: <strong>₹953.83 crore</strong> in revenue, <strong>₹66.67 crore</strong> in profit. The standout figure is operating cash flow, which jumped to <strong>₹85.90 crore</strong> from just <strong>₹26.45 crore</strong> a year earlier. That improvement is driven by tighter working capital. The board stuck with the <strong>₹1.25/share</strong> dividend, unchanged from last year. The auditor's report was clean. There were no surprises, no guidance changes, and no extraordinary items. For a specialty chemicals maker in a slow-growth phase, the cash flow swing is the only thing that separates this from a standard earnings release.</p>
<p>Primary source: <a href="https://www.bseindia.com/corporates/ann.html?scrip=533022&dur=A">BSE</a> · <a href="https://www.nseindia.com/companies-listing/corporate-filings-announcements?symbol=20MICRONS">NSE</a></p>]]></content:encoded>
      <category>Earnings</category>
      <dc:creator>Tipsheet Editorial</dc:creator>
    </item>
    <item>
      <title>20 Microns&#39; FY26 profit grows 6.9%. The filing says nothing else.</title>
      <link>https://tipsheet.markets/20microns-20-microns-fy26-profit-grows-6-9-the-filing-says-nothing-else-95540/</link>
      <guid isPermaLink="true">https://tipsheet.markets/20microns-20-microns-fy26-profit-grows-6-9-the-filing-says-nothing-else-95540/</guid>
      <pubDate>Fri, 22 May 2026 16:15:03 GMT</pubDate>
      <description>Q4 standalone profit rose 16.9%, a stronger finish to a year of modest growth. No new information was disclosed.</description>
      <content:encoded><![CDATA[<p><em>Q4 standalone profit rose 16.9%, a stronger finish to a year of modest growth. No new information was disclosed.</em></p>
<h3>What’s new</h3><ul><li>Standalone Q4 revenue grew ~12% YoY; net profit was up 16.9%.</li><li>Full-year standalone revenue grew 3.7%, net profit 6.9%.</li><li>Consolidated Q4 revenue grew 14.8%, net profit 15.6%.</li></ul>
<h3>Why it matters</h3><p>This is a routine earnings release confirming steady, single-digit full-year growth. The Q4 acceleration to double-digit profit growth is a mild positive, but the filing provides no new strategic or financial information to alter a view on the company.</p>
<h3>What we’re watching</h3><ul><li>Whether the Q4 acceleration carries into FY27.</li><li>Any margin commentary on the quarterly concall.</li><li>Investor reaction to a results set with zero surprises.</li></ul>
<h3>The full read</h3><p>20 Microns' FY26 results are out. Standalone revenue for the year grew <strong>3.7%</strong>, net profit <strong>6.9%</strong>. The fourth quarter was brighter: revenue up <strong>12%</strong>, profit up <strong>16.9%</strong>. Consolidated numbers tracked similarly, with Q4 revenue up <strong>14.8%</strong> and profit up <strong>15.6%</strong>. The board also recommended a <strong>₹1.25</strong> per share dividend. The filing contains no new information. There is no guidance, no strategic update, no surprise. A routine check-in. The Q4 acceleration is a mild positive, but the full-year growth pace is too slow to be a catalyst on its own.</p>
<p>Primary source: <a href="https://www.bseindia.com/corporates/ann.html?scrip=533022&dur=A">BSE</a> · <a href="https://www.nseindia.com/companies-listing/corporate-filings-announcements?symbol=20MICRONS">NSE</a></p>]]></content:encoded>
      <category>Earnings</category>
      <dc:creator>Tipsheet Editorial</dc:creator>
    </item>
  </channel>
</rss>